menu ☰
menu ˟

Lenalidomide, 2nd line therapy, for a patient with aggressive epidermotropic CD8+ peripheral cutaneous T cell Non Hodgkinâ?Ts Lymphoma, post allogeneic stem cell transplant to stabilise disease prior to donor lymphocyte infusion

Creator:

Islington PCT

Subject Keywords: Non-Hodgkin lymphoma, Lenalidomide, Exceptional treatments, individual treatments, Clinical exceptions
Type: Report
Region: United Kingdom
Description:

refer to the resource

Date:

01/01/2009

Rights: refer to the resource
Suggested citation:

Islington PCT. (2009) Lenalidomide, 2nd line therapy, for a patient with aggressive epidermotropic CD8+ peripheral cutaneous T cell Non Hodgkinâ?Ts Lymphoma, post allogeneic stem cell transplant to stabilise disease prior to donor lymphocyte infusion [Online]. Available from: http://publichealthwell.ie/node/26562 [Accessed: 16th September 2019].

  

View your saved citations and reading lists

Contributor:

APHO
 
Click here to view all the resources gathered from this organisation's website.